Evidence Hub

No association between rs6295 of and risk of migraine: Evidence from meta-analysis

Parvinder Kumar, Amrit Sudershan, Bashir Ahmad Sheikh, S. Malik, Hardeep Kumar

IP Indian Journal of Neurosciences, 2024

Abstract

Migraine is considered a complex disorder with polygenic inheritance and is associated with a variant i.e., rs6295 has been hypothesized to be involved in determining the disease susceptibility. Therefore, in the present study we aimed to find the risk between the rs6295 and migraine susceptibility using a meta-analysis approach. The present study utilizes the PRISMA guideline to review existing literature to perform pooled analysis, and also includes quality assessment, association analysis, publication, and heterogeneity analysis using the NOS tool, OR with 95% CI, tests of Begg's with Egger's test, and χ2 based on Cochran's Q Test with I tests respectively. In the present study we didn’t observe any statistical association between the rs6295 and risk of migraine (allele: 1.01 [0.83-1.22], p-value=0.92). Further sub-grouping based on the clinical sub-type, no association was observed in either group i.e., MA (allele: 1.02 [0.73-1.40], p-value=0.90) and MWA (allele: 1.03 [0.75-1.41], p-value0.83). In the present analysis after critical analysis, it was observed that rs6295 didn’t pose any significant risk to the disease susceptibility.

How strong is the evidence?

Evidence Hub reads this as a meta-analysis. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free